399 related articles for article (PubMed ID: 38413011)
1. Drug resistance mechanisms in cancers: Execution of pro-survival strategies.
Dhanyamraju PK
J Biomed Res; 2024 Feb; 38(2):95-121. PubMed ID: 38413011
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance in cancer: an overview.
Housman G; Byler S; Heerboth S; Lapinska K; Longacre M; Snyder N; Sarkar S
Cancers (Basel); 2014 Sep; 6(3):1769-92. PubMed ID: 25198391
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
Shah K; Rawal RM
Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
[TBL] [Abstract][Full Text] [Related]
4. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
5. Understanding and targeting resistance mechanisms in cancer.
Lei ZN; Tian Q; Teng QX; Wurpel JND; Zeng L; Pan Y; Chen ZS
MedComm (2020); 2023 Jun; 4(3):e265. PubMed ID: 37229486
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular paradigms of multidrug resistance in cancer.
Vaidya FU; Sufiyan Chhipa A; Mishra V; Gupta VK; Rawat SG; Kumar A; Pathak C
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1291. PubMed ID: 33052041
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.
Legras A; Pécuchet N; Imbeaud S; Pallier K; Didelot A; Roussel H; Gibault L; Fabre E; Le Pimpec-Barthes F; Laurent-Puig P; Blons H
Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28771186
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications.
Wium M; Ajayi-Smith AF; Paccez JD; Zerbini LF
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806258
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy.
Ye J; Wu J; Liu B
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188866. PubMed ID: 36842765
[TBL] [Abstract][Full Text] [Related]
11. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
12. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
13. The Different Mechanisms of Cancer Drug Resistance: A Brief Review.
Mansoori B; Mohammadi A; Davudian S; Shirjang S; Baradaran B
Adv Pharm Bull; 2017 Sep; 7(3):339-348. PubMed ID: 29071215
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Dzobo K; Sinkala M
OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
[TBL] [Abstract][Full Text] [Related]
15. Cancer Chemoresistance; Recent Challenges and Future Considerations.
Adil M; Kanwal S; Rasheed S; Iqbal M; Abbas G
Cancer Treat Res; 2023; 185():237-253. PubMed ID: 37306912
[TBL] [Abstract][Full Text] [Related]
16. Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance.
Deng J; Wang Y; Lei J; Lei W; Xiong JP
Tumour Biol; 2017 Apr; 39(4):1010428317697553. PubMed ID: 28381160
[TBL] [Abstract][Full Text] [Related]
17. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.
Costea T; Vlad OC; Miclea LC; Ganea C; Szöllősi J; Mocanu MM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936346
[TBL] [Abstract][Full Text] [Related]
18. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies.
Shi ZD; Pang K; Wu ZX; Dong Y; Hao L; Qin JX; Wang W; Chen ZS; Han CH
Signal Transduct Target Ther; 2023 Mar; 8(1):113. PubMed ID: 36906600
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.
Pouya FD; Gazouli M; Rasmi Y; Lampropoulou DI; Nemati M
Mol Biol Rep; 2022 Jun; 49(6):5165-5178. PubMed ID: 35212928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
